Meet OM1

Translating Data and AI into Actionable Evidence & Insights

Many device companies struggle with meeting post-market evidence requirements, demonstrating economic value of therapies, and addressing complex, under-penetrated patient care pathways.

At OM1, we're tackling these challenges head on by combining high-quality RWD, cutting-edge AI methods, advanced platforms, and therapeutic and scientific expertise to transform how products are developed, commercialized, and delivered at the point of care.

Lifecycle Management

Launch & Commercialization

Clinical Trials Phase 2 & 3

Registries, Safety, & Long-Term Follow-Up

How We Help

Automate Registries & Studies

Transform your registries, safety and long-term follow-up studies with OM1’s study automation, data collection and processing platforms.

Generate Precision Insights

Apply PhenOM^TM, our patented AI technology, to answer your most challenging questions with insights around diagnoses, treatments, risk, and clinical trials enrollment

Activate Real-World Analytics

Tap into real-world datasets and conduct analyses to improve evidence-based decisions, estimate market size, understand treatment patterns, and expand access.

Drive evidence-based medicine forward with rapid, digitized data collection and automated registries powered by OM1 Aspen

Flexible, reusable design
Continuous stream of RWD
Accelerate study timelines and drastically reduce costs
Recruit high volumes of patients and minimize burden on sites and patients
Increase patient diversity and reduce bias
Linked data with ability to adapt and expand

Answer your most challenging questions with personalized and actionable insights powered by PhenOM

Learn more about what PhenOM^TMcan do for you

Understand patterns and expand access with specialized data & analytics

Tap into real-world datasets generated from our extensive provider networks, including cardiometabolic, neurology, respiratory/ENT and more:

Explore More

PODCAST

Leveraging Real-World Data for Precision Obesity Treatment

WEBINAR

Registries 101 Advancing Best Practice Guidelines, Methodology, & Innovation

WEBINAR

Overcoming EU MDR Challenges with Real-World Data

Why Customers Choose OM1

Thought-leader in government-led best practices

PI, editors, and authors for Registries for Evaluating Patient Outcomes: A User’s Guide (AHRQ) publication. Now in it’s 4th Edition.
PI and team for the Registry of Patient Registries (AHRQ, National Library of Medicine)
PI and team for the Outcome Measures Framework (HHS)
Awarded HHS “CAPSTONE” to implement standardized outcome measures for depression in research and clinical practice (including patient-facing)

Trusted by 50% of the largest medical device companies and 9 out of top 10 pharmaceutical companies

Running 7+ years, OM1’s largest sponsored program includes 1 million patients, generated numerous publications, and used to demonstrate comparative effectiveness and value for different stakeholders

Experience with 300+ registries with 15 million patients

Specialization in chronic conditions with unique, longitudinal, multi-source, electronically connected real-world datasets and networks across 7 therapeutic areas

Developed and first to implement the OM1 Real-World Data Network registry model to reduce clinician and patient burden and reduce bias by leveraging HIT and advanced technologies

Strategic partnerships with specialty associations, such as the American Academy of Otolaryngology, and integration with their registries

Patented AI & phenotypic technology built on complex models that isolate patient patterns and synthesizes them into actionable insights

What customers are saying

OM1’s strength rests above all on its outstanding tech capabilities. You can link different datasets across a wide spectrum of systems. Few can match that. We have not seen better.”

OM1 is the true leader in RWE for epidemiological/treatment pattern studies...a leading provider in this niche in core diseases.”

It takes a long time to build trust towards quality of data coming from RWE vendors. We have stuck with OM1’s data due to its breadth and high value to us.”

The network of data sources and enduring customer relationships that OM1 have makes it difficult for others to compete.”

The strength of our registry (with OM1) is that we can be flexible, shift our focus and publish meaningful research.”